Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will make its debut at the upcoming annual Swiss Biotech Day conference in Basel.
The first appearance of enGenes at this central event in Europe’s biotech industry calendar underlines the increasing importance of its leading-edge upstream and downstream process development technologies to Switzerland’s biotechnology hub.
Global Village networking
The enGenes team at the Congress Center in Basel will be led by its CEO, Dr. Jürgen Mairhofer and Head of Business Development, Dr. Karl Hübler. They will use the conference’s Global Village and many other networking opportunities to showcase the contribution that its proprietary high-yield biomolecules production platform enGenes -eXpress can make to the economics of all sorts of biotech projects (biopharma and industrial biotech).
“We are very pleased to be able to join the Swiss Biotech Association and guests from around the world to mark the tenth anniversary of this event that has become so important to our industry,” said Dr. Mairhofer.
For more information follow https://www.pharmaceutical-networking.com/engenes-biotech-to-make-debut-at-swiss-biotech-day-conference/
